| FXAIX | LKEQX | FXAIX / LKEQX | |
| Total Expense Ratio | 0.01 | 0.80 | 2% |
| Annual Report Gross Expense Ratio | 0.01 | 0.98 | 2% |
| Fund Existence | 15 years | 30 years | - |
| Gain YTD | 13.739 | 7.945 | 173% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 737B | 510M | 144,510% |
| Annual Yield % from dividends | 1.11 | 0.44 | 253% |
| Returns for 1 year | 13.24 | -2.48 | -534% |
| Returns for 3 years | 74.21 | 20.65 | 359% |
| Returns for 5 years | 100.10 | 19.64 | 510% |
| Returns for 10 years | 248.43 | 84.04 | 296% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SIXZ | 28.92 | 0.11 | +0.38% |
| AllianzIM US Lrg Cp 6M Bfr10 May/Nov ETF | |||
| REVS | 27.59 | -0.05 | -0.18% |
| Columbia Research Enhanced Value ETF | |||
| BBH | 189.89 | -0.62 | -0.33% |
| VanEck Biotech ETF | |||
| IDMO | 53.02 | -0.25 | -0.47% |
| Invesco S&P International Dev Momt ETF | |||
| DIVG | 31.64 | -0.24 | -0.75% |
| Invesco S&P 500 Hi Div Grwrs ETF | |||